vi Executive Summary
BACKGROUND
In Kenya, the maternal mortality ratio remains high at 488 deaths per 100,000 live births with 35 per cent of these deaths arising from unsafe abortion. Public debate on abortion and on proposals to liberalize the abortion law has been on-going for several years in the country. With the passing of a new Constitution in 2010, there was renewed interest in the right to health and the need to reduce the high levels of maternal morbidity and mortality arising from unsafe abortion in the country. In 2012, for instance, the Government issued Standards and Guidelines for Reducing Morbidity and Maternal from Unsafe Abortion that emphasized professional nonjudgmental counseling and provision of safe options in cases of unplanned, risky or unwanted pregnancies in line with the Constitution. The Constitution, on the other hand, stipulates that abortion is permissible if in the opinion of a trained health professional, there is need for emergency treatment, or the life or health of the mother is in danger or as determined by any other law. Apart from the legal and policy discourses, medical abortion using a combination treatment of Mifepristone and Misoprostol has been classified by WHO as a safe and effective method to stop a pregnancy up to 9 completed weeks since the last menstrual period i.e. during the first trimester. The two drugs are registered in Kenya for various indications, including treatment of incomplete abortion and miscarriage, treatment and prevention of post-partum haemorrhage (PPH), treatment of intrauterine foetal death, cervical ripening, and as a uterotonic drug to induce or increase uterine contractions. In spite of the developments, there is limited understanding of the extent to which the changes have influenced the provision of medical abortion information and services in the country, the acceptability of the practice among providers and clients, and the content of care offered.
OBJECTIVES
The overall goal of the study was to generate evidence on the availability, use and quality of care for medical abortion services in private facilities (pharmacies and clinics) in Kenya. The specific objectives of the study were to: (1) understand the contextual and programmatic factors that influence or are likely to influence the provision of medical abortion services in Kenya; (2) explore the perspectives (positive and negative) of various stakeholders about abortion generally and the provision of medical abortion services specifically; (3) assess the availability of Mifepristone and Misoprostol or other abortifacient as well as the skills and practices of private providers; (4) examine the knowledge and attitudes of private providers regarding Mifepristone and Misoprostol or other abortifacients; (5) determine the characteristics, choices and perceptions of clients seeking abortion services from private clinics; and (6) explore the information and services given to clients seeking medical abortion services from private pharmacies and clinics. Private facilities were targeted because access to information and services on medical abortion in Kenya is mainly through private practitioners while public health facilities mostly provide post-abortion care services. Private clinics are operated by the cadres of providers that fall within the legal definition of a health professional including doctors, clinical officers, nurses and midwives while registered pharmacists and enrolled pharmaceutical technologists are the only cadres of health personnel qualified to dispense medicines and operate private pharmacies in the country.
METHODS
This was a cross-sectional study that was conducted between April and June 2013 in Nairobi, Kisumu and Mombasa counties. The study involved: (1) key informant interviews with 19 senior managers from national and locally-based international institutions representing policy, program, research and donor interests in reproductive health in general and medical abortion in particular; (2) structured interviews with 235 pharmacy workers in 235 private pharmacies; (3) 401 simulated client visits to 142 private pharmacies whose workers participated in the structured interviews; (4) structured interviews with 45 in-charges of private clinics; (5) 141 observations of client-provider interactions during consultations in 32 of the 45 private clinics; and (6) 125 exit interviews with clients seeking abortion services in the 32 private clinics. The interviews with key informants were transcribed, typed in Word and analysed for content using NVIVO software. Analysis involved coding of themes and categorizing the themes within a hierarchical framework of main and sub-themes. Quantitative data from structured interviews with pharmacy workers, simulated client visits to pharmacies, structured interviews with facility in-charges, observations of client-provider interactions, and exit interviews with clients were entered in EpiData and analysed using STATA. Analysis involved simple descriptive statistics including percentages, means and medians. vii 
KEY FINDINGS
Abortion Environment: Perspectives of Key Informants  Although there has been progress in the legal and policy frameworks regarding abortion to increase the availability of safe and legal services, many service delivery challenges still persist. Limited dissemination of relevant documents and lack of clear and officially endorsed policy statements to guide public health facilities mean that there is a lack of awareness about the revised service standards and guidelines among service providers and the conditions under which safe abortion services can be legally provided.
 Although several non-governmental organizations and professional associations have developed curricula and supported training of service providers, especially from the private sector, on comprehensive abortion care, values clarification and attitude transformation and referrals, there is no standard training curriculum while skills gaps still persist among providers.
 Effective delivery of safe legal abortion services are further affected by societal stigma, poor access to appropriate information especially among those from marginalised settings, inadequate supply of drugs due to few established distribution channels, poor packaging and storage of relevant drugs, availability of counterfeits, and price distortion brought about by some of these challenges.
Abortion Services in Private Pharmacies
 Very few pharmacy workers (16%) whose outlets provided abortion information or methods had been trained on the provision of the services with trainings focusing more on ensuring confidentiality and privacy of clients, history taking, and pain management, and less on the national standards and guidelines, recordkeeping and reporting, criteria for referral procedures and the recommended regimens for the combination of Mifepristone and Misoprostol.
 There was limited stocking of Misoprostol or Mifepristone even in pharmacies that provided abortion information or methods with only 18% of such pharmacies selling Misoprostol, 2% sold Mifepristone while none sold the combination of Mifepristone and Misoprostol. In addition, most of the pharmacies did not have the national standards and guidelines document on reducing maternal mortality and morbidity from unsafe abortion.
 There was limited knowledge of the correct regimen for Misoprostol only (22% of males and 16% of females) or for combination of Mifepristone and Misoprostol (13% of males and 3% of females) for pregnancies of various gestational ages among pharmacy workers who knew about the medications.
 Although nearly all pharmacy workers (97%) felt that clients seeking Mifepristone and Misoprostol from pharmacies should have a prescription from a medical practitioner, only 11% indicated having ever denied clients abortion services because of lack of a prescription while the most common reasons for denial of services were religious or moral beliefs or lack of a trained provider.
 Pharmacy workers performed poorly on all indicators of interactions with simulated clients although the chances of asking about gestational age (55% of interactions) and advising clients on where to obtain services for pregnancy termination (50% of interactions) were higher than those of discussing family planning (12% of interactions), recommending family planning (9% of interactions), offering a method (1% of interactions), or referring clients elsewhere for family planning (1% of interactions).
Abortion Services in Private Clinics
 The most common aspects related to the provision of abortion services that private providers had received in-service training on were infection prevention (78% of facilities), referral procedures (76% of facilities); and managing complications (76% of facilities) while the least aspects were the national standards and guidelines (60% of facilities) and the legal and policy provisions regarding abortion (51% of facilities).
 Availability of drugs and supplies for medical abortion was very limited (15% of items) although the proportion of items that were in stock on the day of interview was similar to what were reported to be available. By contrast, facilities had most of the drugs and supplies for surgical abortion (81% of items) as well as for recovery, pain management and treatment of complications (85% of items) although the viii proportions of items that were in stock on the day of interview were lower than what was reported to be available.
 Although providers mostly cited health reasons (64% of providers) and preservation of the mother's life (43% of providers) as the common legal grounds for induced abortion, about a quarter (23%) noted that induced abortion can be provided on request, which is contrary to existing laws and regulations. In addition, only about half (49%) of providers whose facilities stocked Misoprostol mentioned the correct regimen for pregnancies of various gestational ages.
 Two-thirds (66%) of the women seeking abortion services from private clinics were aged between 20 and 29 years, 64% had at least secondary level education, 59% were never married while 56% had a previous pregnancy, with the majority of those who had more than one pregnancy (86%) reporting having a previous abortion.
 More than half (59%) of clients seeking abortion services had pregnancies of up to 9 weeks with the most common reason for seeking abortion services being that the pregnancy was unplanned (73%) while other reasons included the need to continue with education (24%), family pressure (14%), and the need to continue with employment (14%).
 Providers recommended the correct regimen for gestational age in only 31% of consultations in which medical abortion (Misoprostol alone or combination of Mifepristone and Misoprostol) was recommended. By contrast, providers recommended manual vacuum aspiration for 54% of pregnancies of up to 9 weeks, 59% of pregnancies above 9 and below 12 weeks, 31% of pregnancies between 12 and 14 weeks, and 58% of pregnancies over 14 weeks.
 Although nearly all (98%) private clinics reported providing family planning information or methods, only 79% of the clients seeking abortion services were counselled on family planning while 48% were given a method. Besides, elements of family planning counselling were some of the least performed functions during consultations (40% of elements performed) while elements of interpersonal relationships such as courteous handling of clients were some of the most performed by providers (74% of elements performed).
 The majority of clients seeking abortion services (78%) had previously used a family planning method, mostly male condom, oral pills, injectables, and emergency pill. Nearly two-thirds (63%) chose a method on the day of visit, mostly injectables (40%), male condoms (33%), pills (20%), implants (18%), and IUCDs (18%) while 60% of those who had a previously used a method chose a different method, mostly injectables, IUCD and implants.
 Prices of medical abortion drugs increased with higher gestation age of pregnancy although there were wide variations in the prices facilities charge for the methods, ranging from KSh. 90 (≈US $1) to KSh. 7,000 (≈US $82). Prices of surgical abortion methods also varied widely between facilities from KSh. 1,500 (≈US $18) to KSh. 15,000 (≈US $176).
IMPLICATIONS
 There is need for widespread and government-endorsed dissemination of the revised laws, policies, standards and guidelines on abortion services among health care providers for improved clarity regarding the provision of safe legal abortion services.
 There is need for a standard approach to improving the capacity of private providers to offer safe abortion services including having a standard training curriculum, which incorporates counselling on proper use of medication, family planning (especially long-term methods) and referrals for clients seeking abortion services.
 There is need to address some of the barriers to delivery and uptake of safe legal abortion services such as stigma and lack of access to information through public awareness especially regarding existing laws and policies on abortion and available services.
 There is need to ensure proper packaging of medical abortion products and to address the issue of counterfeits, for instance, by designing unique moisture-proof packages with bar codes that would be difficult to imitate to reduce the chances of users getting substandard products which can compromise their health.
ix  There need to improve the supply chain to reduce stock-outs of essential drugs (especially combined Mifepristone and Misoprostol) in private pharmacies and clinics that provide abortion information or methods. (Sedgh et al. 2014) . Most of the abortions are considered unsafe i.e. they are performed by untrained practitioners or provided in unhygienic settings (Singh et al. 2009; WHO 2004) . Unsafe abortion accounts for 13 per cent (47,000) of global maternal deaths worldwide while about 60 per cent of abortion-related deaths take place in Africa (Shah and Åhman 2010; United Nations 2010) .
Globally, WHO estimated that there were 21.6 million unsafe abortions worldwide in 2008 with Africa having the second highest rate of unsafe abortion (28 per 1,000 women aged 15-44 years) after Latin America and the Caribbean which had a rate of 35 (WHO 2011) . The rate of unsafe abortions was also higher in regions with restrictive compared to those with less restrictive abortion laws (WHO 2011) . Studies show that although abortion is restricted in many countries in sub-Saharan Africa except for circumstances when the pregnancy endangers the life of the mother, abortion-related complications account for the majority of admissions to gynecological wards of hospitals in the region (Levandowski et al. 2012 (Levandowski et al. , 2013 Singh et al. 2005) .
In Kenya, the maternal mortality ratio remains high at 488 deaths per 100,000 live births with 35 per cent of these deaths arising from unsafe abortion (Centre for Reproductive Rights 2010; Kenya National Bureau of Statistics [KNBS] and ICF Macro 2010; Ministry of Health 2003) . A 2013 study that used patient-specific data for women who sought abortion-related care at health facilities found that the rate of induced abortions in the country was 48 per 1,000 women aged 15-49 years in 2012, higher than the 2002 rate of 45 per 1,000 women (Republic of Kenya 2013). The study further found that 37 per cent of the women seeking post-abortion care services had severe complications such as high fever, sepsis, shock and organ failure, indicating that abortion might have occurred under unsafe conditions (Republic of Kenya 2013).
Public debate on abortion and on proposals to liberalize the abortion law has been on-going for several years in Kenya (Brookman-Amissah and Moyo 2004) . With the passing of a new Constitution in 2010, there was renewed interest in the right to health and the need to reduce the high levels of maternal morbidity and mortality arising from unsafe abortion in the country (Republic of Kenya 2010a; 2012). In 2012, for instance, the Government issued Standards and Guidelines for Reducing Morbidity and Maternal from Unsafe Abortion that emphasized professional non-judgmental counseling and provision of safe options in cases of unplanned, risky or unwanted pregnancies in line with the Constitution (Republic of Kenya 2012). The Constitution, on the other hand, stipulates that abortion is permissible if in the opinion of a trained health professional, there is need for emergency treatment, or the life or health of the mother is in danger or as determined by any other law (Republic of Kenya 2010a). Furthermore, Article 43(1)(a) of the Constitution states that every person has the right to the highest attainable standard of health, which includes the right to health care services, including reproductive health care (Republic of Kenya 2010a).
Apart from the legal and policy discourses, medical abortion using a combination treatment of Mifepristone and Misoprostol has been classified by WHO as a safe and effective method to stop a pregnancy up to 9 completed weeks since the last menstrual period i.e. during the first trimester (WHO 2012) . Misoprostol is registered in Kenya as a multi-purpose drug whose indications include duodenal ulcer, gastric ulcer, treatment of incomplete abortion and miscarriage, treatment and prevention of post-partum haemorrhage (PPH), treatment of intrauterine fatal death and cervical ripening. Mifepristone is also registered as a medication indicated for duodenal ulcer, gastric ulcer, cervical ripening and as a uterotonic drug to induce or increase uterine contractions. The availability of these two drugs in the country could replace surgical and non-surgical invasive methods that have previously been used to terminate pregnancies, both illegally and legally (Ong'ech et al. 2008) .
In spite of the developments, there is limited understanding of the extent to which the changes have influenced the provision of medical abortion information and services in the country, the acceptability of the practice among providers and clients, and the content of care offered. This report presents findings from a study whose aim was to generate evidence on the current knowledge about medical abortion, availability of the services, as well as the nature of information exchange between clients and private providers (clinics and pharmacies). The study was conducted in three counties, namely, Nairobi, Kisumu, and Mombasa between April and June 2013. The counties were purposively selected based on availability of private clinics that were likely to provide medical abortion drugs. Private providers were targeted because access to information and services on medical abortion in Kenya is mainly through private practitioners while public health facilities mostly provide post-abortion care services (Wamugi et al. 2014 Key informants were persons aged 18 years and above. The interviews were conducted in English and were tape-recorded with the consent of the informants. The interviews were transcribed, typed in Word and analysed for content using NVIVO software. Analysis involved coding of themes and categorizing the themes within a hierarchical framework of main and sub-themes. The thematic framework was used to compare and contrast patterns of the themes between different key informants. The data from the interviews provide contextual information on the status of medical abortion in Kenya.
FINDINGS
Key informants reported that since the enactment of the 2010 Constitution, the abortion environment has been changing rapidly especially with respect to the legal and policy frameworks, training of service providers, service delivery, and availability of abortion commodities (equipment and drugs) although challenges remain.
Legal and Policy Frameworks
Key informants noted that there have been some developments in the legal and policy frameworks regarding abortion in Kenya. For instance, all key informants felt that the Standards and Guidelines for Reducing Morbidity and Mortality from Unsafe Abortion in Kenya was a good reference material that offered clear guidance for health workers who offer abortion services, as well as clarifying situations in which the health worker might not be willing to provide services due to personal beliefs. As one key informant noted:
So far I think it's [the Standards and Guidelines] a good one. I think its good enough to start off with. We can improve. It is giving the women and the service providers all the options. If you have an unwanted pregnancy, it gives you the option to adoption. The last part of it takes care of all the providers. The last one was only the doctors or a psychiatrist. If the providers are educated on it well, they can understand it well. I feel it's a good one. We now have a reference material.
Despite availability of the standards and guidelines document, key informants noted that it is yet to be disseminated widely, which has in turn affected its full implementation. MOH representatives stated that dissemination has been hampered by lack of adequate funds. In addition, the MOH has not issued a policy statement (through a circular or otherwise) that can be followed by public health facilities. These policy gaps have sometimes been exploited by the police to harass health workers known to provide abortion services legally. Key informants reported that:
Very few people even at our level know what the guidelines say. It was just last week we were planning to do a survey in [name of facility] to look at the efficacy and efficiency of the two tier levels on the use of Misoprostol and post-abortion care. When we applied for approval from the hospital ethical committee, the first comment they gave us was by asking who gave midwives the authority to offer post-abortion care. So I had to come back to the office and carry a hard copy. The issue is that people are not aware, there are documents and so we need to disseminate.
The legislation/policy needs to be very clear, and then we need to sensitize the health workers across the board for them to understand how the law protects them. It is a journey. But just saying the constitution has been passed and the standards and guidelines have been developed won't work.
Training of Service Providers
Key informants reported that in spite of the provider trainings that have been undertaken by various organizations, major skills and performance gaps in safe abortion services among health care providers remain. These include:  Poor knowledge of treatment protocols and drug dosages: This was largely because most health care providers have not read the protocols and drug specifications as outlined in the service standards and guidelines document.  Poor counselling skills: Apart from nurses, other cadres of health care providers lack adequate counselling skills, which were attributed to lack of pre-service training.  Poor surgical skills: Some doctors were reported to have the medical knowledge but lack practical skills for performing surgical abortion.  Lack of skills in patient assessment specific to abortion: Many providers have skills in general patient assessment, but lack skills specific to abortion including physical examination.  Poor skills in infection prevention and management of abortion complications: This is mostly among mid-level service providers (clinical officers, nurses and mid-wives).  Lack of service integration: This is particularly with respect to linking women to other services such as family planning.
The informants reported that the skills and performance gaps could be addressed through well planned inservice trainings on safe abortion in the short term but will require to be incorporated in the pre-service curriculum in the long term. They further noted that in-service trainings should follow a standard curriculum to ensure that there is a common approach to provision of safe abortion services as opposed to a situation where trainings are done using different curricula developed by different institutions as has been the case.
Service Delivery
Key informants reported that, ideally, it should be possible for a woman to receive safe and legal abortion services in public health facilities. However, the focus in the public sector is still on the management of postabortion complications. There is still reluctance and apprehension to provide medical abortion services mainly due to the lack of a clear policy statement on abortion in the public sector. Key informants further noted that besides the limited dissemination of the standards and guidelines, provision of safe abortion services in public health facilities is hindered by negative provider attitudes and beliefs. It was reported that some health care workers decline to offer services due to their religious beliefs (i.e. conscientious objection) or the widespread social stigma associated with abortion. A health care provider reported that:
I do not mind what the Constitution says, my personal opinion is that we need to address. I think telling people the solution to irresponsible sexual behaviour is abortion [is wrong]. I think people are worried about pregnancy and not the consequences of unprotected sex, that is what we need to address. In emergency cases where there is rape and other cases, the services can be availed, but in situations where it is at will and in the era of HIV/AIDS, we need to be cautious.
Informants identified various challenges/barriers to women's ability to access safe medical abortion services to include:  Stigma: Both the women seeking the services and the providers offering the services are stigmatized, for example, being referred to as 'baby killers'. Facilities identified to be offering safe abortion services are also stigmatized by the general public.  Inadequate number of trained health providers: Although progress has been made with in-service training of health workers, the numbers are still insufficient to meet demand.  Inadequate supply of drugs: Whereas Misoprostol and Mifepristone are registered, the distribution network is not yet well established. The drugs are readily available in major urban areas but scarce in small towns and rural areas.  Cost: The price of the drugs in areas where there is limited supply was also reported to be out of reach of poor women and the youth. For instance, while the actual cost of Misoprostol could be as low as KSh. 20, it was reported that in some places it could cost as high as KSh. 1,000.  Ignorance about the law: Many people are still not aware of the provisions of the Constitution regarding abortion services. Furthermore, others interpret the law narrowly in order to deny women services.  Limited number of facilities that provide safe abortion services: There are not many publicly known facilities that provide the services, while those that do are mostly found in urban areas and are mainly privately owned. In addition, lack of clear policy statement has acted as a barrier to the provision of safe abortion services in public health facilities.  Quality of care: This is affected by the secretive nature of providing abortion services; hence clients may obtain counterfeit commodities from people operating unregistered facilities. Providers' poor counselling skills as well as lack of awareness about service standards and guidelines also affect quality of care.  Poor access to information: Women in urban slums and rural areas and especially younger women lack information on where to get safe abortion services and/or advice.
Availability of Supplies, Equipment and Drugs
Informants noted that the registration of medical abortion drugs-Misoprostol and Mifepristone-represented major progress towards addressing unsafe abortions in Kenya. Misoprostol has also been included in the essential drug list which makes it possible for public health facilities to procure it. Various stakeholders, including drug companies, non-governmental organizations and networks of providers, now procure and distribute abortion drugs and equipment to private health facilities that are in need. However, informants identified a number of challenges affecting the supply chain (importation, storage, distribution and marketing) of medical abortion commodities. They noted that the challenges are severe at the supply/distribution stage, as evidenced by the pricing of medical abortion drugs. As one informant noted:
As I said, the main challenge is the distribution outlets. If you are in [name of town], you need to go there and get the products at an affordable price. One time in [another town], I walked into a chemist and asked for Misoprostol, the lady told me I needed a prescription but I managed to convince her I was a health worker and she accepted. One tablet goes for KSh. 600 while a tablet here [name of facility] goes for KSh. 20, so you can imagine how many women are suffering. So the problem is at distribution and the cost.
The specific challenges with the supply chain that informants identified included:  Importation bottlenecks: Similar to other medical products, challenges with importing medical abortion drugs and surgical abortion kits include paying for the products upfront, theft at customs, and delays in clearance by the customs authorities. These processes are time consuming and result in delays in getting the products to those who need them.  High price of products: The price of abortion products was noted to be generally high and this is occasioned by poor supply and distribution channels. There are very few companies and organizations involved in the procurement of abortion commodities. The limited distribution channels in the country pushes the prices of commodities beyond the reach of health facilities and clients.  Poor packaging and storage of drugs: Poor packaging of Misoprostol has been experienced, with some batches absorbing moisture, especially when poorly stored.  Availability of counterfeits: Counterfeits are available for Misoprostol and manual vacuum aspiration (MVA) kits especially in Nairobi. The supply of counterfeits compromises the provision of safe abortion services since quality cannot be guaranteed. Counterfeits also affect the pricing of commodities and legitimate providers are likely to lose out.
SUMMARY AND IMPLICATIONS

Summary of Findings
 Although there has been progress in the legal and policy frameworks regarding abortion to increase the availability of safe and legal services, many service delivery challenges still persist. Limited dissemination of relevant documents and lack of clear and officially endorsed policy statements to guide public health facilities mean that there is a lack of awareness about the revised service standards and guidelines among service providers and the conditions under which safe abortion services can be legally provided.
Implications
 The finding that gaps still exist with respect to provider skills despite trainings conducted by different partners suggest the need for a standard approach to improving the capacity of providers to offer safe abortion services including having a standard training curriculum.
INTRODUCTION
Private pharmacies in Kenya play a critical role in ensuring access to essential medicines by those in need. The 2010 Kenya National Pharmaceutical Policy (KNPP) recognizes the right to access essential medicines especially by vulnerable population groups as part of the fundamental right to health as enshrined in the Constitution (Republic of Kenya 2010b). According to the policy, registered pharmacists and enrolled pharmaceutical technologists are the only cadres of health personnel qualified to dispense medicines and operate private pharmacies in the country (Republic of Kenya 2010b). However, private pharmacies face challenges that might affect the way consumers benefit from essential medicines. From a public health perspective, private pharmacies may lack the incentives to take up important steps in promoting rational decision-making by consumers including counselling on proper use of medicines or providing referrals for appropriate care. This could be attributed to the nature of training for pharmacists (which may not include the provision of public health information and services) and the fact that interactions with clients at private pharmacies are mostly with frontline staff some of whom lack formal training in health service provision (PATH 2004) . Private pharmacy providers are further faced with the challenge of balancing operations as a business establishment and performing the role of health service providers (Skibiak et al. 2001; PATH 2004) .
The registration of Mifepristone and Misoprostol in Kenya made them part of the essential drugs list for distribution and sale through registered outlets including private pharmacies. The medications are distributed to registered private pharmacies and clinics by recognized distributors including Marie Stopes International for Misoprostol and Maxima Pharmaceuticals Limited for Mifepristone. The medications are registered for sale over the counter with prescriptions from a medical practitioner. Challenges associated with medicines being sold as commodities as well as those faced by private pharmacies may affect the way the two medications are sold to and used by consumers. There is, however, limited understanding of private pharmacy providers' knowledge of the medications and existing regulations, how they dispense the medications and how they generally interact with clients seeking abortion services. The objectives of this component of the study were: 1) To assess the availability of Mifepristone and Misoprostol or other abortifacient as well as the skills and practices of workers in private pharmacies; 2) To examine the knowledge and attitudes of private pharmacy workers regarding Mifepristone and Misoprostol or other abortifacients; and 3) To explore the information given to clients seeking medical abortion services at private pharmacies.
METHODOLOGY
This component of the study involved structured interviews with private pharmacy workers and simulated client visits to the pharmacies.
Interviews with Pharmacy Workers
In each county, 100 pharmacies were randomly sampled from the list of all registered private pharmacies. It is common for pharmacies and chains of pharmacies to be owned by one proprietor who employs workers to provide services to clients. For each sampled pharmacy, the owner was approached to provide written informed consent for his/her pharmacy to be included in the study. Of the 300 sampled pharmacies, owners of 274 granted consent (82 in Nairobi, 93 in Kisumu and 99 in Mombasa). Subsequently, trained research assistants visited these 274 pharmacies to conduct interviews with the pharmacy workers. One most senior pharmacy worker was interviewed in each pharmacy. To be eligible for interview, the pharmacy worker had to be actively involved in dispensing drugs, should have worked for at least six months at the pharmacy, and gave individual written informed consent. Interviews were completed with 235 pharmacy workers (82 in Nairobi, 80 in Kisumu and 73 in Mombasa), 36 refused (11 in Kisumu and 25 in Mombasa) while 3 interviews were only partially completed (2 in Kisumu and 1 in Mombasa).
The interviews aimed at determining the availability of medical abortion services as well as knowledge, attitudes and practices of the workers regarding the services. Information was captured on the background characteristics of pharmacy workers (sex, age, education level and training), their knowledge of medical abortion products and regimens, service provision practices at the pharmacy, and the cost of Misoprostol and Mifepristone. Pharmacy workers were approximately equally male and female, with an average age of 31 years (range of 22 to 58 years). Nearly all (97%) had secondary education and above. The majority (56%) worked at pharmacies in peri-urban areas, 34% were in pharmacies in the central business district of each urban centre, while 10% were in rural areas. The majority (80%) were employees and 92% reported that they were trained to dispense medicines.
Simulated Client Visits
The simulated client approach was used to understand service provision practices followed for clients seeking abortion services at pharmacies. Simulated clients were females aged between 18 and 31 years, and trained to assume one of the following four specific profiles of clients seeking medical abortion services from a pharmacy:
 Scenario 1: A woman specifically wanting to purchase Misoprostol without stating a reason;  Scenario 2: A woman specifically wanting to purchase Misoprostol and stating that the reason is to end a pregnancy without stating the gestation period;  Scenario 3: A woman seeking any medication to end an 8-week pregnancy; and  Scenario 4: A woman seeking any medication to end a 12-week pregnancy (i.e. after the recommended threshold gestation).
In each county, about half of the pharmacies whose workers were interviewed were visited by simulated clients. A total of 401 simulated client visits were made (136 in 53 pharmacies in Nairobi, 134 in 49 pharmacies in Kisumu, and 131 in 40 pharmacies in Mombasa). Each pharmacy was visited an average of three times (minimum one, maximum 4) on different dates at least one week after the structured interviews with the pharmacy workers, over a period of one month. The minimum time period between visits was three days. No pharmacy was visited more than once by the same simulated client. Within one hour of each visit, the simulated client completed a structured questionnaire to record details of their interaction with the pharmacy workers including any information and product they were given. The visits were equally distributed among the four scenarios, i.e. 100 visits per scenario.
Data Analysis
Data from structured interviews with pharmacy workers and simulated client visits were entered in EpiData and analysed using STATA. Analysis involved simple descriptive statistics including percentages, means and medians. For simulated client data, Chi-square tests were performed to determine if differences between scenarios were statistically significant.
RESULTS
Staffing Levels and Staff Training
The median number of staff at the pharmacies was 8 with a minimum of 1 and maximum of 8 persons. Only 16% of the pharmacy workers who reported that their outlets provided abortion services (information or methods) had been trained on the provision of the services with wide variations between counties (52% in Nairobi, 15% in Kisumu and 2% in Mombasa). In addition, 10% of the pharmacy workers who reported that their outlets did not provide abortion services indicated that they had been trained to provide the services (12% in Nairobi, 11% in Kisumu and none in Mombasa). Pharmacy workers who indicated that they had been trained were asked to specify the aspects in which they had been trained (Figure 1 ). Most had been trained in ensuring confidentiality and privacy of clients (97%), history taking (91%), and pain management (88%), and relatively few had been trained in the national standards and guidelines (34%), record-keeping and reporting (38%) and criteria for referral procedures (38%). Misoprostol-only regimen was the most common method that pharmacy workers had been trained in, followed by MVA, dilatation and curettage, and dilatation and evacuation (Figure 2 ). Less than 10% of the trained pharmacy workers had been trained in Mifepristone-only (6%) or the recommended combination of Mifepristone and Misoprostol regimens (9%). 
Availability of Abortion Services
More than half (58%) of the pharmacy workers interviewed indicated that they provided advice or information on pregnancy termination to clients seeking the services although there were wide variations by county (65% in Kisumu, 29% in Nairobi and 84% in Mombasa). The most commonly provided information were referral to a health facility (71%), continuing with the pregnancy (60%), and seeking counselling services on how to manage the pregnancy (36%). Only 4% of the pharmacy workers reported that they provided methods of pregnancy termination to clients seeking the services (1% each in Kisumu and Mombasa and 9% in Nairobi). Nine out of ten provided Misoprostol only. Ninety five per cent of the pharmacy workers whose outlets provided abortion information or methods indicated that they sold family planning methods as well, which Percent provides an opportunity to offer such clients the methods. The most commonly sold methods in these outlets were pills (95%), male condoms (91%), emergency contraceptives (89%), and the 3-month injectables (75%).
Among pharmacies whose workers reported that they provided abortion information or methods, 18% indicated that they sold Misoprostol only, 2% sold Mifepristone only while none sold the combination of Mifepristone and Misoprostol. The most commonly reported reasons for selling the medications were for controlling peptic ulcers (68%), labour induction (28%), controlling postpartum haemorrhage (24%), and treating incomplete abortion (12%).
About two-thirds (67%) of the pharmacy workers who reported that they did not provide abortion information or methods indicated that clients asked for those services. In most cases, they referred clients elsewhere (49%) or advised them against procuring an abortion (40%). Those who reported referring clients elsewhere mostly referred them to private health facilities (78%). Others made referrals to public health facilities (54%) and general practitioners (8%).
Availability of Drugs and Supplies
Among pharmacies that provided information or methods on abortion, the most commonly available supplies were policy on confidentiality of clients (89%), policy on record-keeping and reporting (87%), Misoprostol (66%), and referral mechanisms (52%). The least available items were Mifepristone (2%), WHO Technical and Policy Guidance on Safe Abortion and the National Standards and Guidelines for abortion care ( Figure  3 ). 
Prices of Medical Abortion Methods
The average price of Misoprostol based on information obtained from pharmacy workers ranged from KSh. 74 (≈US $0.87) to KSh. 530 (≈US $6) depending on the brand ( 
Knowledge and Attitudes of Pharmacy Workers
Misoprostol alone was the most commonly known abortion medication among private pharmacy providers (86% of males and 76% of females) followed by Mifepristone alone (46% of males and 28% of females) while the combination of Mifepristone and Misoprostol was the least known ( Figure 4) . However, only 22% of males (N=103) and 16% of females (N=86) who had heard of the medications mentioned the correct regimen for Misoprostol only for pregnancies of various gestational ages. Similarly, only 13% of males (N=55) and 3% of females (N=32) mentioned the correct regimen for combination of Mifepristone and Misoprostol (Figure 4) . A small proportion (3%) of the pharmacy workers felt that clients seeking abortion services should be able to get the drugs from pharmacies without a prescription. 
Service Provision Practices
Slightly more than a quarter (27%) of pharmacy workers whose outlets provided abortion information or methods reported ever denying clients the services (32% of males and 20% of females; Table 2 ). The most common reasons for denying clients the services were religious or moral beliefs (57%), lack of trained provider (38%), lack of permission from third parties (19%), lack of appropriate equipment (14%), and lack of prescription from a medical practitioner (11%). In addition, 35% of pharmacy workers whose outlets provided abortion information or methods indicated that they screened clients (31% of males and 40% of females) while 7% advised clients to return for follow-up visits (8% of males and 7% of females; Table 2 ). Screening of clients mostly involved asking for reasons of seeking to terminate pregnancy, asking about gestational age of the pregnancy, asking about client's background characteristics, conducting medical examination, asking for prescription, asking about medical history, and asking for proof of permission from third parties (not shown). With respect to interactions with simulated clients, there were significant variations in the practices of pharmacy workers by the scenario presented. In particular, the proportion of visits for which pharmacy workers asked about the last menstrual period, gestational age, medical history, reasons for pregnancy termination, and proof of permission from third parties were highest when simulated clients sought medication to terminate a three-month pregnancy (scenario 4) and lowest when they just asked for Misoprostol without stating reason (scenario 1; Table 3 ). Similarly, the proportion of visits for which pharmacy workers advised clients to continue with the pregnancy or gave information about where to obtain pregnancy termination services, available methods of pregnancy termination, and surgical abortion methods were highest under scenario 4 and lowest under scenario 1. By contrast, the proportion of visits for which providers asked for prescriptions from a medical practitioner and discussed medical abortion methods was highest under scenario 1 (Table 3) .
For all visits combined, pharmacy workers performed poorly on all indicators; the highest scores were for asking about gestational age (55%) and advising clients on where to obtain services for pregnancy termination (50%). In addition, despite the fact that most pharmacies providing abortion information or services also sold family planning methods, family planning was discussed with simulated clients in only 12% of the visits (Table 3) . Similarly, pharmacy workers recommended family planning in 9% of visits, offered a method in 1% of visits, and referred clients elsewhere for family planning in 1% of visits (Table 3 ). 
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SUMMARY AND IMPLICATIONS
Summary of Findings
 Very few pharmacy workers (16%) whose outlets provided abortion information or methods had been trained on the provision of the services with trainings focusing more on ensuring confidentiality and privacy of clients, history taking, and pain management, and less on the national standards and guidelines, record-keeping and reporting, criteria for referral procedures and the recommended regimens for combination of Mifepristone and Misoprostol.
Implications
 There is need to improve the capacity of pharmacy workers to offer appropriate information including proper use of medication, family planning and referrals to clients seeking abortion services.
 There is need to improve the supply chain to reduce stock-outs of essential drugs (especially combined Mifepristone and Misoprostol) in private pharmacies that provide abortion information or methods.
 There is need for widespread dissemination of the existing policies and guidelines among pharmacy workers to ensure that they provide services within existing regulations.
INTRODUCTION
Private clinics in Kenya are operated by the cadres of providers that fall within the legal definition of a health professional including doctors, clinical officers, nurses and midwives. The clinics are registered by the Kenya Medical Practitioners and Dentists Board, the Clinical Officers Council or the Nursing Council of Kenya depending on the qualification of the provider operating the clinic. It is also common for private providers to be part of a network or franchise that aims at improving institutional sustainability of the clinics and the quality of care that they provide. In spite of the regulatory and institutional oversight available for private clinics in the county, the nature of care provided at the outlets may still be affected by other factors such as the resources at the disposal of the provider, availability of appropriate services, choices that clients make, technical competence of providers as well as how they interact with clients including mechanisms for follow-up (Bruce 1990 ).
In the context of abortion services, care at private clinics may be affected by some of the challenges identified by key informants (see section on "Abortion Environment") including inadequate training, limited awareness about relevant policies and guidelines, poor supply and distribution chain for essential medicines, and the social stigma associated with the practice. However, little is known about the provision of medical abortion in private clinics in the country, the acceptability of the practice among providers and clients, as well as the content of care given to clients. The objectives of this component of the study were: 1) To assess the availability of Mifepristone and Misoprostol or other abortifacient as well as the skills and practices of providers in private clinics; 2) To examine the knowledge and attitudes of providers in private clinics regarding Mifepristone and Misoprostol or other abortifacients; 3) To determine the characteristics, choices and perceptions of clients seeking abortion services from private clinics; and 4) To explore the quality of care given to clients seeking abortion services from private clinics.
METHODOLOGY
This component of the study involved structured interviews with in-charges (managers) of private clinics, observations of client-provider interactions during consultations, and structured exit interviews with clients seeking abortion services.
Interviews with Facility In-charges
Structured interviews were conducted with facility in-charges of 45 private clinics that provide abortion services (11 in Kisumu, 18 in Nairobi, and 16 in Mombasa). The facilities were randomly sampled from among those that were members of the Reproductive Health Network and/or the AMUA Franchise that is managed by Marie Stopes Kenya. A minimum of 10 facilities were targeted in each County. The interviews with the in-charges included an inventory to determine the available infrastructure, staffing levels and skills mix, equipment, commodities, and supplies needed for surgical and medical abortion services. The facility in-charges were also asked about their knowledge and practices as well as the prices of abortion services available at the facility. Almost one-half (47%) of the in-charges were nurses or midwives, 36% were clinical officers, 9% were gynaecologists, and 9% were community health workers. Two-thirds of in-charges were male. On average, the providers had worked in health care for 19 years, although females had worked longer (average of 24 years) compared to males (average of 16 years).The providers had worked at the facilities where they were interviewed for an average of 9 years with females having worked slightly longer (11 and 7 years respectively).
Observations of Client-Provider Interactions
Observations of client-provider interactions during consultations were in conducted in private clinics with clients and providers who had given their consent to be observed during the provision of a medical abortion procedure. A total of 141 observations were conducted in 32 out of the 45 private clinics that were included in the study (62 in 11 clinics in Kisumu, 58 in 12 clinics in Nairobi and 21 in 9 clinics in Mombasa). Two observations were partially completed (1 in Kisumu and 1 in Mombasa) because the clients needed referrals to higher level facilities. The observations were conducted by trained nurses to determine the nature and quality of services that clients received. The nurses used a structured checklist adapted from the WHO Technical and Policy Guidance on Safe Abortion (WHO 2012) and the National Standards and Guidelines for Reducing Morbidity and Mortality from Unsafe Abortion in Kenya (Republic of Kenya 2012). They observed aspects of history taking, pre-procedure counselling, medical examination, provision of medical abortion, and post-abortion care information provided to clients.
Client Exit Interviews
Immediately after the observations, consenting clients were requested to participate in an exit interview to determine their perceptions of the services provided and their overall impression of the provider's behaviour during the consultation. Interviews were completed with 125 clients (48 in 11 clinics in Kisumu, 56 in 12 clinics in Nairobi and 21 in 9 clinics in Mombasa). Six interviews were partially completed and eight clients who were observed during the consultation refused the interview. Information was collected on their background characteristics (such as age, education level, marital status, religious affiliation, and household assets and amenities), childbearing experiences and intentions, family planning knowledge and use, and perceptions about the services received. The interviews were conducted in English, Kiswahili or a mixture of both depending on the clients' preference by a research assistant who was paired with the nurse conducting the observations.
Data Analysis
All data were entered in EpiData and analysed using STATA. Analysis involved simple descriptive statistics including percentages, means and medians. Composite scores were computed to determine availability of drugs and supplies as well as the quality of care that clients received. The results are presented in the form of the fraction of elements that were available in the clinics or that were performed by providers during interactions with clients. Tables A1 and  A2 in the Appendix present the list of items that were used to compute the scores for service availability and quality of care respectively.
RESULTS
Staffing Levels and Staff Training
The clinics had, on average, 4 medical and 1 support staff, with facilities in Nairobi having the highest median number of providers, followed by those in Mombasa and Kisumu (Table 4) . However, facilities had on average only 1 staff member trained on medical abortion, comprehensive post-abortion care or family planning, while none was trained on values clarification and attitude transformation. Facilities in Kisumu had higher numbers of staff members trained on medical abortion and family planning (Table 4 ). Further analysis showed that the most common aspects related to the provision of abortion services that clinic staff had received in-service training on were infection prevention (78% of facilities), referral procedures (76%); and managing complications (76%; not shown). The least aspects that staff had been trained on were the national standards and guidelines (60% of facilities) and the legal and policy provisions regarding abortion (51%; not shown). Other aspects that staff had been trained on included pregnancy screening (67% of facilities), communication/counselling (69%), medical examination of clients (69%), history taking (71%), pain management (71%), record-keeping/reporting (71%), and confidentiality/privacy of clients (73%; not shown). Service Availability
Eighty per cent of the clinics offered at least one surgical abortion method and a similar proportion offered at least one medical abortion method (Table 5) . MVA was the most common surgical abortion method, while Misoprostol alone was the most common medical abortion method available in the clinics. Almost all (91%) facilities offered either surgical or medical abortion methods, while 69% offered both methods. Only 11% of the facilities had Mifepristone alone, while 18% had a combination of Mifepristone and Misoprostol, reflecting the fact that Mifepristone had just been registered a few months before the study.
More than 90% of facilities conducted or had conducted at least one procedure related to pre-abortion, pain management, infection prevention or control, and management of complications (Table 5) . However, only 33% of facilities conducted all the procedures related to pre-abortion care, while none had conducted all the procedures related to pain management, infection prevention or control, and management of complications. Virtually all facilities (98%) reported that they provide family planning information or methods as a separate service. However, only 53% reported that they provide additional information on when to seek further care and less than half reported providing information on prevention of sexually transmitted infections (STIs) or HIV (49%), self-care after leaving the health facility (42%), and resumption of sexual activity (15%; ). Table A1 in the Appendix section for the list of items; STIs: Sexually transmitted infections; Differences between study sites are statistically significant at: *p<0.05; **p<0.01.
Availability of Drugs, Supplies and Equipment
Interviewers asked facility in-charges and also requested to see whether various drugs, supplies and equipment for abortion services were available at the facility and in stock on the day of the visit. The clinics had most of the drugs and supplies for surgical abortion (81% of items) as well as for recovery, pain management and treatment of complications (85% of items; Table 6 ). However, the proportions of these items that were in stock on the day of interview were lower than what was reported to be available. The clinics also had most of the infrastructural facilities needed to ensure quality care for clients (91% of items; Table 6 ). The facilities also had about two-thirds of the equipment for surgical or medical abortion (68% of items) and services standards and guidelines on abortion (69% of items). Availability of drugs and supplies for medical abortion at the clinics was very low (15%) although the proportion of items that were in stock on the day of interview was similar to what was reported to be available (Table 6 ). Provider Knowledge and Attitudes
Knowledge, attitudes and practices of facility managers are likely to influence the provision of abortion services at health facilities. Facility in-charges were asked about the common legal grounds for procuring induced abortion in the country and whether permission from third parties is required before performing abortion. Providers mostly cited health reasons (64% of providers), preservation of life (43% of providers), and low socio-economic status of clients (30%) as the common legal grounds for induced abortion (table 7) . About a quarter (23%) of the providers noted that induced abortion can be provided on request, which is contrary to existing laws and regulations. Slightly more than half (55%) of the providers reported that permission from third parties (mostly from parents/ guardians or spouses/partners) is needed before performing abortion. About half (49%) of providers whose facilities stocked Misoprostol mentioned the correct regimen for pregnancies of various gestational ages (Table 7) while all providers whose clinics stocked the combination of Mifepristone and Misoprostol mentioned the correct regimen (not shown). 
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Service Provision Practices
About three-quarters (78%) of the providers reported that there were instances when their facilities denied abortion clients the services. The most common reasons were because they could not afford to pay (46%), inappropriate gestational age (34%), clients' health status was not conducive (20%), and lack of appropriate equipment (20%; Figure  5 ). A significantly higher proportion of male compared to female providers reported inappropriate gestational age as the reason for denying abortion clients the services while a significantly higher proportion of female than male providers reported stock-outs and religious or moral concerns as reasons for denying abortion clients services (p<0.05 in each case). With respect to observations of client-provider interactions during consultations, the most commonly performed elements were courteous handling of clients (74% of elements performed) and provision of pre-abortion information (60% of elements performed; Table 8 ). The least provided services were providing recommendations following medical examination of clients (17% of elements performed), counselling on family planning (40% of elements performed), and conducting medical examination (45% of elements performed). In all cases, the performance of the elements was highest in Kisumu and lowest in Nairobi (Table 8) . Further analysis showed that providers recommended MVA to clients in 57% of the consultations, Misoprostol alone in 30% of the consultations, and combination of Mifepristone and Misoprostol in 9% of the consultations (not shown).
Distribution by gestational age showed that providers recommended MVA for 54% of pregnancies of up to 9 weeks, 59% of pregnancies above 9 and below 12 weeks, 31% of pregnancies between 12 and 14 weeks, and 58% of pregnancies over 14 weeks (not shown). In addition, providers recommended the correct regimen for gestational age in only 31% of consultations in which medical abortion (Misoprostol alone or combination of Mifepristone and Misoprostol) was recommended. For 43 consultations in which Misoprostol alone was recommended, providers explained the mode of action in 88% of the cases, and for the 12 consultations where combination of Mifepristone and Misoprostol was recommended, providers explained the mode of action in 11 cases (not shown).
Almost all clients (93%) were given post-abortion care medication with the highest in Nairobi and lowest in Mombasa ( Figure 6 ). Although 98% of facilities indicated that they provided family planning information or methods (Table 5) , clients were counselled on family planning in 79% of the consultations and offered family planning methods in only 48% of consultations, with wide variations between study sites. Few clients were referred to another facility for further help (13% of consultations). Characteristics of Clients Seeking Abortion Services
The majority of clients who were observed during consultation and interviewed upon exit were aged between 20 and 29 years (66%; Table 9 ). Whereas more than half of the clients in Kisumu (54%) and Mombasa (52%) had primary level education or lower, the majority in Nairobi (64%) had college-level education. Nearly three-quarters (73%) of the clients in Kisumu were from the two poorest wealth quintiles, 57% of clients in Nairobi were from the two richest wealth quintiles, and a similar proportion of clients in Mombasa were from the middle and richer quintiles. Many clients (59%) were never married although there were significant differences between study sites, with the majority of clients in Mombasa (43%) being formerly married (separated, divorced or widowed). More than half (56%) of the clients had been pregnant more than once (Table 6 ) while 54% had not given birth. Among those who had given birth, 53% had two or more living children. Sixty per cent of the clients had intention to have children in future while the majority (78%) desired fewer than 5 children. Clients' Experiences and Need for Abortion Services Clients who had been pregnant more than once were asked about their previous experiences with miscarriages, still births and abortions. Twenty per cent of them reported having a previous miscarriage or still birth with a significantly lower proportion of clients in Kisumu (4%) compared to those in Nairobi (26%) and Mombasa (39%) reporting such experiences (Table 10 ). The majority (86%) who had more than one pregnancy reported having a previous abortion, with significant differences between study sites.
During consultations, observers noted whether the provider asked clients the reasons for wanting to terminate the pregnancy, and if so, the explanations that clients gave. Providers asked for such reasons in 83% of the consultations. The most commonly given reasons were that the pregnancy was unplanned (73%), the need to continue with education (24%), family pressure (14%), and the need to continue with employment (14% ; Table 10 ). Interestingly, only two percent of pregnancies were a result of family planning method failure (not shown).
Observers further noted whether the provider established and recorded the gestational age of the pregnancy. Providers established the gestational age of the pregnancy in 90% of the consultations with more than half (59%) of clients seeking abortion services at 9 weeks and below while 10% sought services at more than 14 weeks of pregnancy (Table 10 ). Notes: a Among those with two or more pregnancies; b Based on observations of client-provider interactions for consultations where the provider asked for reasons for wanting to terminate pregnancy; c Based on observations of client-provider interactions for consultations where the provider determined the gestational age of pregnancy; Differences between study sites are statistically significant at: *p<0.05; **p<0.01.
Clients' Knowledge and Use of Family Planning
Clients seeking abortion services were asked about their knowledge and prior use of family planning methods. Ninety eight per cent of the clients reported knowing a family planning method with no significant differences between study sites. The majority (78%) reported having ever used a family planning method with no significant differences between study sites. The most common methods clients had ever used were male condom, oral pills, injectables, and emergency pill (Figure 7 ).
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Figure 7: Per cent distribution of clients who had ever used a family planning method by type of method Notes: IUCD: Intra-uterine contraceptive device; Number of cases=97.
Eighty percent of the clients who had ever used family planning obtained a method themselves or together with their partners the last time, while 19% reported that their partners obtained the method. Among clients who obtained a method by themselves or together with their partners, 36% got it from private pharmacies, 35% from private health facilities, and 22% from public health facilities (Figure 8 ). Upon exit, clients were asked whether they decided to use a family planning method and if so, which method. Nearly two-thirds (63%) chose a family planning method, most commonly injectables (40%), male condoms (33%), pills (20%), implants (18%), and IUCDs (18%). Eleven per cent of these clients had not previously used family planning while among those who had previously used a method, 60% chose a different method. Figure 9 shows a dramatic decline in the use of oral pills and increases in the use of injectables, IUCD and implants among clients who had previously used a method. 
Clients' Perceptions of Services Received
In all study sites, clients highly rated the consultation process with 96% of the elements reported as having been performed by the providers (Figure 10 ). By contrast, providing information on the services being given was the least rated component of the interactions with clients reporting only 58% of the elements being performed by the providers. Overall ratings of the consultation process and information provided were highest in Kisumu and lowest in Nairobi while rating for history taking and medical examination was highest in Kisumu and lowest in Mombasa (Figure 10 ). Clients were asked upon exit how long they waited before being seen by the provider from the time they arrived at the facility, and whether they felt that it was reasonable. Most clients (88%) reported that the waiting time was reasonable with no significant differences between study sites. The average waiting time was 13 minutes (9 minutes in Kisumu, 16 minutes in Nairobi, and 17 minutes in Mombasa). Most (45%) clients waited between 10 and 29 minutes ( Figure  11 ) with wide variations between study sites. 
Prices of Abortion Services
Facility in-charges were asked about the prices of surgical and medical abortion services available at the clinics. The median cost of MVA was KSh. 3,000 (≈US $35) while that of dilatation and evacuation or dilatation and curettage was KSh. 5,000 (≈US $58; Table 11 ). The median price of the Misoprostol only regimen increased with higher gestation age of pregnancy while the median price for the combination of Mifepristone and Misoprostol for pregnancies of up to 9 weeks was KSh. 5,000 (≈US $58). There were wide variations in the prices facilities charge for the methods (Table  11) . One provider reported the price of KSh. 5,000 (≈US $58) for combination of Mifepristone and Misoprostol for pregnancies of gestational age of above 9 and below 12 weeks.
Clients were asked upon exit how much they paid for additional elements of abortion service, including transport, consultation card, laboratory tests, other medication, counselling, and family planning methods. The results in Table  11 show that clients' expenses on surgical abortion methods (MVA or dilatation and evacuation were quite high. In addition, consultation fee was, on average, higher than the cost of medication. Cost of Misoprostol regimen 9 weeks and below 360 5,000
2,500 16
Above 9 and below 12 weeks 180 5,000
3,000 10
Between 12-14 weeks 90 7,000 4,500 6
Cost of combination of Mife and Miso 9 weeks and below 1,000 7,000 5,000 5
Above 9 and below 12 weeks a --
--1
Expenses incurred by clients Client expenses on Transport 10 800
67
Consultation 100 5,400
2,000 73
Card 50 8,500
17
Laboratory tests 99 400
25
Medication 200 6,500
1,400 22
Family planning method(s) 50 3,500
10
Manual vacuum aspiration 300 7,000
4,000 18
Miso and manual vacuum aspiration 3,500 5,000
4,250 2
Dilatation and evacuation 8,000 10,000
9,000 2
Notes: a One provider reported KSh. 5,000; KSH: Kenya shilling (1 USD ≈ KSH. 85).
SUMMARY AND IMPLICATIONS
Summary of Findings
 The most common aspects related to the provision of abortion services that private providers had received inservice training on were infection prevention (78% of facilities), referral procedures (76% of facilities); and managing complications (76% of facilities) while the least aspects were the national standards and guidelines (60% of facilities) and the legal and policy provisions regarding abortion (51% of facilities).
 Availability of drugs and supplies for medical abortion was very limited (15% of items) although the proportion of items that were in stock on the day of interview was similar to what were reported to be available. By contrast, facilities had most of the drugs and supplies for surgical abortion (81% of items) as well as for recovery, pain management and treatment of complications (85% of items) although the proportions of items that were in stock on the day of interview were lower than what was reported to be available.
 More than half (59%) of clients seeking abortion services had pregnancies of up to 9 weeks with the most common reason for seeking abortion services being that the pregnancy was unplanned (73%) while other reasons included 28 the need to continue with education (24%), family pressure (14%), and the need to continue with employment (14%).
 Providers recommended the correct regimen for gestational age in only 31% of consultations in which medical abortion (Misoprostol alone or combination of Mifepristone and Misoprostol) was offered. By contrast, providers recommended manual vacuum aspiration for 54% of pregnancies of up to 9 weeks, 59% of pregnancies above 9 and below 12 weeks, 31% of pregnancies between 12 and 14 weeks, and 58% of pregnancies over 14 weeks.
Implications
 There is need for widespread dissemination of the existing policies and guidelines regarding abortion among private providers to ensure that they offer services within existing regulations.
 There is need to improve the supply chain for medical abortion drugs (especially combined Mifepristone and Misoprostol) in private clinics.
 There is need strategies to improve the capacity of private providers to offer appropriate family planning services to clients seeking abortion, especially long-term methods given the high rate of repeat abortions.
Study Limitations
One of the limitations of the study stems from the technique of observing clients and providers during consultations as it is likely that providers may bias their behaviour in a positive way. To address this issue, all observers had medical qualifications as this was expected to raise the comfort levels of the providers such that their behaviours become normative. In addition, it was emphasized during training that at the beginning of the observation the observers should let the providers know that they were not there to evaluate them and that the observers were not experts who could be consulted during the session.
A second limitation was that although facilities were randomly sampled from among those that were members of RHN or the AMUA Franchise, the clients were not randomly sampled as they were observed or interviewed upon exit based on their expressed willingness to participate voluntarily in the study. It could be that those who accepted to participate in the study were self-selecting based on a greater willingness to share their experiences regarding this stigmatized behaviour and so their experiences may not be representative of all clients seeking abortion services from private health facilities.
Another limitation stems from the unclear or ambiguous nature of the Kenyan legal status on abortion, which could have induced study participants, especially private pharmacy workers, to deny knowledge of the subject or to provide responses in line with the prevailing legal and socio-cultural context. In addition, given that written informed consent was obtained from the pharmacy proprietor in advance of the simulated client visits, he/she may have instructed employees to change their practice for the period of the study. The simulated client method itself is also prone to certain biases especially the ability of the simulated client to appropriately enact the assigned role and to recall details of the interaction after the event.
Appendices Table A1 3) Showed non-judgemental attitude 4) Talked in a language client understood IX. CLIENT PERCEPTIONS: INFORMATION GIVEN Provider gave information on: 1) What was going to be done 2) What client is likely to experience 3) How long the process would take 4) Risks and complications associated with the process 5) How to manage pain 6) What to do in case of complications 7) When client is likely to resume normal activities 8) Other available options for managing the pregnancy 9) Available psycho-social support services 10) Child-spacing and family planning 11) STIs/HIV 12) Whether and when to return to facility 13) Written materials on services that client received 14) Referral to another clinic for more services X. CLIENT PERCEPTIONS: SATISFACTION WITH SERVICES 1) Facility is clean/tidy 2) Waiting time before seeing provider was reasonable 3) Provider is always available at the facility 4) Provider was responsive/understanding 5) Provider was knowledgeable 6) Drugs/medicines are always available at facility 7) Provider treated client with respect 8) Confidentiality/privacy was ensured 9) Cost of services was reasonable 10) Client was happy overall with services at the facility
